Log In
Print
BCIQ
Print
Print this Print this
 

Epodure

  Manage Alerts
Collapse Summary General Information
Company Medgenics Inc.
DescriptionTransdermal biopump implant device that produces erythropoietin (EPO)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationAnemia
Indication DetailsTreat anemia in chronic kidney disease (CKD) patients; Treat anemia in dialysis patients; Treat anemia in patients with end-stage renal disease (ESRD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today